Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive disease (COPD)/emphysema.

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Vatican authorities said Monday that Pope Francis is suffering from a “polymicrobial respiratory tract infection.” Experts ...

We grew cells in the lab to mimic the lining of the lung, and exposed these cells to both brake dust and diesel exhaust dust.

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

A warning has been issued that drying laundry indoors in winter can lead to lung damage. According to the Daily Express on ...

Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...

SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a reduced risk of COPD exacerbations in patients with type 2 ...